ClinConnect ClinConnect Logo
Search / Trial NCT06321419

Effects of Advanced Trauma Life Support® on Adult Trauma Patient Outcomes

Launched by KAROLINSKA INSTITUTET · Mar 14, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Advanced Trauma Life Support Mortality Disability Return To Work Quality Of Life

ClinConnect Summary

This clinical trial is studying the effects of a training program called Advanced Trauma Life Support® (ATLS®) on the outcomes of adult patients who have experienced trauma, such as wounds or injuries. The goal is to determine whether physicians who have received ATLS® training provide better care and help patients recover more effectively compared to standard care practices. This research is important because, even though ATLS® is widely used around the world, there hasn't been a controlled study to show its benefits for patient outcomes.

To participate in this trial, you must be at least 15 years old and have experienced trauma within the last 48 hours before arriving at the hospital. You will be treated at one of the participating hospitals in India, which handle a significant number of trauma cases each year. If you agree to be part of the study, your treatment will proceed as usual, but researchers will collect information about your care and outcomes to help understand the impact of ATLS® training. It’s important to note that your participation carries minimal risk, and the study aims to gather valuable data that could improve trauma care in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age of at least 15 years;
  • trauma occurred less than 48 hours before arrival at the hospital;
  • present to the emergency department of participating hospitals, with a history of trauma defined as having any of the reasons listed in the International Classification of Diseases chapter XX as the reason for presenting;
  • admitted or died between arrival at the hospital and admission, or referred/transferred from the emergency department of a participating hospital to another hospital for admission; and
  • managed by a participating cluster in the emergency department.
  • Exclusion Criteria:
  • present with isolated limb injuries; or
  • are directly admitted to a ward without being seen by a physician in the emergency department.

About Karolinska Institutet

Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.

Locations

Ludhiana, Punjab, India

Mumbai, Maharashtra, India

Dehradun, Uttarakhand, India

Kolkata, West Bengal, India

Chandigarh, , India

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported